BBC NEWSAmericasAfricaEuropeMiddle EastSouth AsiaAsia Pacific
BBCiNEWS  SPORT  WEATHER  WORLD SERVICE  A-Z INDEX    

BBC News World Edition
 You are in: Health 
News Front Page
Africa
Americas
Asia-Pacific
Europe
Middle East
South Asia
UK
Business
Entertainment
Science/Nature
Technology
Health
Medical notes
-------------
Talking Point
-------------
Country Profiles
In Depth
-------------
Programmes
-------------
BBC Sport
News image
BBC Weather
News image
SERVICES
-------------
EDITIONS
Prostate test counselling 'vital'
blood test tube
Blood tests can point to the presence of prostate cancer
Men deserve to hear the full facts before being asked to undergo a test which could reveal prostate cancer, says an expert.

There are fears that widespread introduction of the Prostate Specific Antigen (PSA) test could lead to many unnecessary operations.

Speaking at the European Cancer Conference in Lisbon on Thursday, a leading prostate specialist from the Netherlands, Professor Fritz Schroder, said it was "unethical" to apply the test without first making sure men understood the implications of a positive, or negative, result.

The PSA test looks for chemical markers in the blood - high levels suggest that the man may have a prostate cancer.

However, two-thirds of men with elevated PSA levels don't actually have the disease, as it could mean they have a simple infection or inflammation of the prostate.


Powerful, early diagnostic tests cannot be withheld from well-informed men. The accent here, however, has to be on well-informed

Professor Fritz Schroder
In addition, some men who have completely normal PSA readings do turn out to have cancer - so it is certainly not a failsafe.

In the US, widespread PSA testing has vastly increased the number of prostate cancers detected, but very many of these are slow-growing tumours in elderly men, and unlikely to pose a direct threat to life.

Nevertheless, many men went ahead with potentially risky surgery to remove the prostate, or radiotherapy treatment, both of which carry a significant risk of leaving the patient impotent, incontinent, or both.

Vulnerable nerves

This is because the prostate gland, lying just under the bladder, is close to a number of tissues important in continence and sexual function - it is difficult for surgeons or radiologists to avoid damaging these at the same time.

One study following prostate removal surgery patients in the US found that 60% were impotent 18 months after surgery, 8% had complete urinary incontinence, and 40% had occasional genitourinary problems of one sort or the other.

Professor Schroder told the conference: "Powerful, early diagnostic tests cannot be withheld from well-informed men.

"The accent here, however, has to be on well-informed."

In many parts of the world, doctors will often advise patients who are found to have a prostate cancer to wait and see how aggressive the tumour is before opting for prostate removal or radiotherapy.

This "watchful waiting" involves check-ups every few months to see if the tumour has increased in size.

The European Cancer Conference - full coverage

Key stories

News imageTHE DISEASE
See also:

17 Mar 00 | C-D
27 Feb 01 | Health
Internet links:


The BBC is not responsible for the content of external internet sites

Links to more Health stories are at the foot of the page.


News image
News imageE-mail this story to a friend

Links to more Health stories

News imageNews imageNews image
News image
© BBCNews image^^ Back to top

News Front Page | Africa | Americas | Asia-Pacific | Europe | Middle East |
South Asia | UK | Business | Entertainment | Science/Nature |
Technology | Health | Talking Point | Country Profiles | In Depth |
Programmes